Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding US labelling requirements.

Maria Donawa1

  • 1Donawa Consulting, Rome, Italy. medonawa@donawa.com

Medical Device Technology
|November 2, 2005
PubMed
Summary
This summary is machine-generated.

Medical device labeling for the European market may not meet United States requirements. Manufacturers must understand the distinct US labeling regulations to ensure compliance and avoid market access issues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

US regulation of combination products.

Medical device technology·2010
Same author

Clinical studies in Italy.

Medical device technology·2010
Same author

Meeting US and European supplier control requirements.

Medical device technology·2009
Same author

Avoiding surprises when implementing a single quality system.

Medical device technology·2009
Same author

Addressing Eeuropean environmental legislation.

Medical device technology·2009
Same author

Addressing US and European device testing requirements.

Medical device technology·2008

Area of Science:

  • Medical Device Regulation
  • International Compliance
  • Labeling Standards

Background:

  • Medical device manufacturers operate in a global market with varying regulatory landscapes.
  • European labeling requirements are established under specific directives and regulations.
  • United States labeling requirements are governed by the Food and Drug Administration (FDA).

Purpose of the Study:

  • To highlight critical differences between European and United States medical device labeling requirements.
  • To inform manufacturers about potential compliance pitfalls when using European labels in the US.
  • To provide a comparative overview of key labeling elements for both markets.

Main Methods:

  • Comparative analysis of European Union (EU) medical device labeling regulations.

Related Experiment Videos

  • Review of relevant United States Food and Drug Administration (FDA) labeling guidelines.
  • Identification of specific information and symbol discrepancies between the two regulatory frameworks.

    • Main Results:

    • Significant variations exist in symbol usage, terminology, and required information between EU and US medical device labels.
    • Information suitable for the European market may be insufficient or non-compliant with US FDA regulations.
    • Manufacturers may face regulatory challenges and delays if US requirements are overlooked.

    Conclusions:

    • Medical device manufacturers must not assume cross-market label compatibility between Europe and the US.
    • Thorough understanding and adaptation to specific US labeling requirements are essential for market access.
    • Proactive assessment of labeling differences is crucial for regulatory compliance and successful product distribution in the United States.